UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
25.11+0.49 (+2.01%)
As of 12:43PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
360,911
377,709
60,920
51,844
24
Operating expenses
Research development
422,553
437,381
311,594
387,087
103,179
Selling general and administrative
120,047
116,813
87,805
57,222
29,605
Total operating expenses
542,600
554,194
399,399
444,309
132,784
Operating income or loss
-181,689
-176,485
-338,479
-392,465
-132,760
Total other income/expenses net
-245
-1,352
63,004
21,836
-62,883
Income before tax
-133,370
-131,161
-260,178
-370,638
-194,592
Income tax expense
-
1,366
3,410
0
0
Income from continuing operations
-134,736
-132,527
-289,088
-370,638
-194,592
Net income
-134,736
-132,527
-289,088
-370,638
-194,592
Net income available to common shareholders
-134,736
-132,527
-289,088
-370,638
-195,869
Basic EPS
-4.17
-1.72
-4.13
-5.77
-4.19
Diluted EPS
-4.17
-1.72
-4.13
-5.77
-4.19
Basic average shares
74,623
77,152
70,015
64,228
46,733
Diluted average shares
74,623
77,152
70,015
64,228
46,733